# Efficacy and Safety Study in the Prevention of Antibiotic-Associated Diarrhea (AAD) and Clostridium Difficile-Associated Diarrhea (CDAD) in Hospitalized Adult Patients Exposed to Nosocomial Infection

> **NCT00958308** · PHASE3 · COMPLETED · sponsor: **Bio-K Plus International Inc.** · enrollment: 255 (actual)

## Conditions studied

- Antibiotic-Associated Diarrhea
- Clostridium Difficile-Associated Diarrhea

## Interventions

- **OTHER:** BIO-K+ CL-1285®
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00958308
- **Lead sponsor:** Bio-K Plus International Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-03
- **Final completion:** 2009-04
- **Target enrollment:** 255 (ACTUAL)
- **Last updated:** 2012-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00958308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00958308, "Efficacy and Safety Study in the Prevention of Antibiotic-Associated Diarrhea (AAD) and Clostridium Difficile-Associated Diarrhea (CDAD) in Hospitalized Adult Patients Exposed to Nosocomial Infection". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00958308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*